MYXOFIBROSARCOMA
Clinical trials for MYXOFIBROSARCOMA explained in plain language.
Never miss a new study
Get alerted when new MYXOFIBROSARCOMA trials appear
Sign up with your email to follow new studies for MYXOFIBROSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New immune combo shows promise in early sarcoma trial
Disease control OngoingThis early-stage study tests whether adding an experimental drug (BO-112) to an immunotherapy (nivolumab) before surgery is safe for people with soft tissue sarcoma that can be removed. The goal is to see if this combination can boost the immune system to better attack the cancer…
Matched conditions: MYXOFIBROSARCOMA
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New combo therapy shows promise for rare sarcomas
Disease control OngoingThis study tests whether adding the drug pazopanib to standard radiation or chemoradiation helps shrink soft tissue sarcomas before surgery. About 140 patients with newly diagnosed, removable tumors took part. The goal is to see if the combination is safe and improves tumor respo…
Matched conditions: MYXOFIBROSARCOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:50 UTC